MedTrace Logo

Trial of Tomotherapy in Breast Cancer

NCT00459628 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2017-05-16

No results posted yet for this study

Summary

Tomotherapy is a new radiation therapy system that uses an integrated CT scanner during delivery of radiation treatment to improve the accuracy of the treatment. Furthermore the irradiation is delivered helicoidally allowing highly conformal shaping of dose distribution. However the magnitude of the clinical advantage of using the system in breast cancer is unknown. The purpose of the present study is to investigate whether or not the Tomotherapy can substantially reduce pulmonary and cardiac toxicities, as compared with conventional radiotherapy.

Conditions

  • Breast Neoplasms

Interventions

RADIATION

Conventional radiotherapy

Radiation treatment delivered by conventional linear accelerator using matching fields

RADIATION

Tomotherapy

CT image guided intensity modulated radiation therapy delivered by the Tomotherapy HiArt system

Sponsors & Collaborators

  • Vrije Universiteit Brussel

    lead OTHER

Principal Investigators

  • Mark De Ridder, MD, PhD · Radiotherapy Department, Universitair Ziekenhuis Brussel

  • Vincent Vinh-Hung, MD, PhD · Radiotherapy-Oncology, Universitair Ziekenhuis Brussel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2011-08-31
Completion
2017-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00459628 on ClinicalTrials.gov